Effects of 12 weeks treatment with solifenacin on Bladder Wall Thickness (BWT) and clinical outcomes: Results from the placebo-controlled SHRINK study

Robinson D1, Khullar V2, Oelke M3, Wijkstra H4, Tretter R5, Stow B5, Compion G6, Tubaro A7

Abstract Category

Detrusor Overactivity

Abstract 422
Non Discussion Poster
Scientific Non Discussion Poster Session 34
Detrusor Overactivity Overactive Bladder Clinical Trial Urgency/Frequency Other [Bladder Wall Thickness ]
1. Kings College Hospital, London, UK, 2. St Mary’s Hospital, Imperial College, London, UK, 3. Hannover Medical School, Hannover, Germany, 4. AMC University Hospital, Amsterdam & Eindhoven University of Technology, The Netherlands;, 5. Astellas Pharma, Leiden, The Netherlands, 6. Astellas Pharma, Chertsey, UK;, 7. La Sapienza University of Rome, Rome, Italy
Links

Abstract